We have observed this in breast cancer models, where elevated Δ40p53 expression impaired p53’s canonical response to doxorubicin, promoting cancer survival, DNA repair and proliferation, while inhibiting apoptotic signalling [31]. Here, TP53 is linked to breast cancer.